Event Details

This course generates understanding of the range of activities that take a new candidate drug molecule through Development, Manufacturing and Commercialization to routine patient use.

It is a highly interactive, clearly explained journey through:

  • Technical development – making the molecule and the medicine
  • Preclinical safety – ensuring drugs are safe enough for patient use
  • Early clinical trials – evaluating viability of new drugs
  • Integrating healthcare with digital support and advanced diagnostics
  • Major trials and Regulatory – proving value and seeking license to market
  • Branding and commercialization for launch
  • Manufacturing and supply chain set up
  • Getting new treatments to patients worldwide

Who Should Attend?

Those who will benefit from an understanding of what is done to bring new treatments from the end of the target/drug discovery stage, all the way to patient use. This is helpful (for example) for:

  • Scientific and technical staff whose organisations may aspire to build their businesses to later stages of development.
  • Service function staff who need to operate better knowing the 'language' of their internal customers.
  • BioPharma service companies' staff who need to better understand clients' business.


  • John Faulkes (Training Consultant at PPMLD)

    John Faulkes

    Training Consultant at PPMLD

    John began his career as a scientist within the Diagnostics subsidiary of Wellcome. He changed careers, moving into training/human resources, ending up as a development business partner in the 1990's. John left to set up his own business and has been independent ever since. He works as a trainer, consultant and coach with a variety of industry sectors, but spends the majority of time working with Ralph in PPMLD, in Pharma / Lifesciences. He is a regular author of journal articles and posts on topics of project leadership, teamworking, alliances and partnerships.

    He has delivered successful development for cross-function project team structures as well as across business partnerships - alliances and outsourced CRO work.

    view more


OBN Memeber Ticket
Member Price £400
OBN Non-member Ticket
Standard Price £550


Venner Shipley LLP

Aldersgate Street 200
England, United Kingdom

If you have any questions please contact Hannah Deacon

Contact Organizer

Show on map